Tag Archives: investment

5 Top-Rated Healthcare Mutual Funds To Add To Your Portfolio

Healthcare mutual funds provide excellent choices for investors looking to enter this safe-haven sector, which is likely to protect their investment during a market downturn. The healthcare sector has proven to be one of the most desirable avenues during difficult times as it does not vary with market conditions. Also, several pharmaceutical companies have a history of paying regular dividends, which can help to offset the losses from plummeting share prices. Below we will share with you 5 top-ranked healthcare mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. FSPHX invests a major portion of its assets in companies involved in designing, manufacturing and selling healthcare products and services. FSPHX invests in companies across the world. The Fidelity Select Health Care Portfolio is a non-diversified fund and has returned 10.6% over the past one year. FSPHX has an expense ratio of 0.74% as compared to a category average of 1.35%. Fidelity Select Biotechnology Portfolio (MUTF: FBIOX ) invests a large share of its assets in companies primarily involved in research, development, manufacture and distribution of various biotechnological products. Factors such as financial strength and economic conditions are considered to invest in companies located anywhere in the world. The Fidelity Select Biotechnology Portfolio is a non-diversified fund and has returned 22.7% over the past one year. Rajiv Kaul is the fund manager and has managed FBIOX since 2005. Turner Medical Sciences Long/Short C (MUTF: TMSCX ) seeks capital appreciation. TMSCX invests a major chunk of its assets in healthcare firms. TMSCX uses a long/short growth strategy for reduction of volatility and capital preservation during a market downturn. TMSCX mainly focuses on acquiring securities of companies having market capitalizations greater than $250 million. TMSCX is expected to maintain a portfolio of 15 to 75 securities long, and 15 to 75 securities short. The Turner Medical Sciences Long/Short C has returned 11.1% over the past one year. TMSCX has an expense ratio of 1.50% as compared to a category average of 1.84%. Fidelity Select Medical Delivery Portfolio (MUTF: FSHCX ) invests largely in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. FSHCX focuses on acquiring common stocks of both US and non-US companies. The Fidelity Select Medical Delivery Portfolio fund is non-diversified and has returned 19.9% over the last one-year period. Steven Bullock is the fund manager and has managed FSHCX since 2012. Fidelity Select Medical Equipment & Systems (MUTF: FSMEX ) seeks capital growth. FSMEX invests the majority of its assets in companies that are primarily involved in medical equipment and devices and the related technologies sector. FSMEX focuses on acquiring common stocks of companies by analyzing factors including financial strength and economic condition. FSMEX invests in both US and non-US companies. The Fidelity Select Medical Equipment & Systems is a non-diversified fund and has returned almost 14.3% over the past one year. As of August 2015, FSMEX held 55 issues with 23.57% of its assets invested in Medtronic PLC. Original Post

Buy: The WisdomTree Japan Hedged Equity ETF

Summary An ETF that invests in dividend paying companies incorporated in Japan and listed on the Tokyo Stock Exchange. The end of 20 years of deflation in Japan makes Japanese equities profitable in the current economic state. Abe’s pledge to further lower the corporate tax will stimulate Japanese stock market. Overview of the WisdomTree Japan Hedged Equity ETF (NYSEARCA: DXJ ) The WisdomTree Japan Hedged Equity ETF is an exchange-traded fund incorporated in the USA. It is designed to “to provide exposure to the securities in Japan, while at the same time hedging exposure to fluctuations between the value of the U.S. dollar and the Japanese yen” (WisdomTree.com). The Index is designed to have higher returns than a similar non-currency hedged investment when the yen depreciates relative to the U.S. dollar. Conversely, the index is designed to have lower returns if the yen strengthens against the U.S. dollar. The Fund invests in dividend paying Japan-incorporated companies that derive less than 80% of their revenue from sources in Japan. By excluding companies that derive 80% or more of their revenue from Japan, the index focuses more on companies with significant global revenue base (SEC). (click to enlarge) (Source: Bloomberg) (click to enlarge) (Source: Wisdomtree) The end of 20 years of Deflation Source: inflation.edu After a 20 year boom led by real estate and stocks during the 1970s and the 1980s, Japan experienced huge deflation for the next 20 years. Japan never recovered to the 2% annual inflation which is the hallmark of a proper financial system. However, as Shinzo Abe was elected Prime Minister of Japan, he initiated the “Three Arrows” policy. The policy entailed: (1) printing money to raise prices (2) buying $75B in bonds each month until March 2015 (3) targeting a 2% annual inflation rate (4) weakening the yen (5) increasing spending to create jobs and (6) delay inevitable tax increases. Why Japanese Equities Investing in Japan can be extremely profitable in the current economic state. In September 2015, the Nikkei 225 stock index experienced its biggest one day jump since 2008 because Prime Minister Abe pledged to further lower the corporate tax rate ( Bloomberg ). Compared to the ROE for Tokyo Stock Price Index in 2009, which was -4%, the ROE for TOPIX is now 8.6%. Hence investors should consider purchasing Japanese equities. This significant increase in ROE is indication of Japan’s economic growth potential. Moreover, Japan is still in the monetary easing mode. This quantitative easing program weakened the yen successfully, making the exportation of Japanese goods easier. (click to enlarge) JPYUSD Spot Exchange Rate (Source: Bloomberg) Abe latest pledge to further lower the corporate tax definitely supports Japanese equities. It increased, however, the debt of the country. Indeed, S&P recently downgraded Japan’s sovereign credit rating (marketrealist). Fortunately for Japan, the QE program is likely support stocks in the foreseeable future. Why DXJ DXJ is a perfect ETF that provides exposure to the Japanese equity market while hedging out the currency fluctuations so that the fund can focus purely on the performance of Japanese stocks. It is the best ETF for investors who believe that the yen will continue to weaken against the dollar but are also still seeking to scoop up Japanese equities. If the investor thinks that the yen will strengthen against the dollar, the fund will underperform other broad based Japanese ETF such as the iShares MSCI Japan ETF (NYSEARCA: EWJ ). (Source: etfdb.com as of 10/9/2015) As the yen weakened during the monetary easing mode and Abe recently lowered corporate taxes, it is apparent that DXJ will start to provide better returns than EWJ. Japan’s QE program will make the Japanese companies to export more goods. Since DXJ is composed of companies whose main revenue source is not Japan, DXJ will benefit from Abe’s policy. Symbol 1 Week 4 Week YTD 1 Year 3 Year 5 Year ProShares UltraShort MSCI Japan ETF (NYSEARCA: EWV ) -7.48% -6.89% -22.21% -26.23% -63.18% -68.52% DXJ 5.13% 3.31% 6.78% 8.19% 75.26% 58.00% EWJ 3.86% 3.07% 8.17% 9.40% 38.10% 27.77% SPDR Russell/Nomura PRIME Japan ETF ( JPP) 3.88% 3.53% 8.68% 10.40% 39.03% 31.10% iShares Japan Large-Cap ETF ( ITF) -2.40% -7.74% 6.10% 1.54% 36.45% 25.62% ProShares Ultra MSCI Japan ETF ( EZJ) 7.56% 7.16% 12.27% 13.61% 65.63% 27.51% Deutsche X-trackers MSCI Japan Hedged Equity ETF ( DBJP) 3.98% 2.79% 7.77% 20.34% 104.74% n/a Precidian MAXIS Nikkei 225 Index ETF ( NKY) 2.54% 1.96% 6.95% 8.76% 39.96% n/a (Source etfdb.com) The above graph is the historical data for Japan Equities ETF. DXJ has the second highest one week return and also the highest five year return, showing strength among other Japan ETFs. Symbol Inception ER Commission Free First Trust Japan AlphaDEX ETF ( FJP) 2011-04-19 0.80% Not Available WisdomTree Japan SmallCap Dividend ETF ( DFJ) 2006-06-16 0.58% E*TRADE WisdomTree Japan Hedged SmallCap Equity ETF ( DXJS) 2013-07-01 0.58% E*TRADE ITF 2001-10-23 0.50% Not Available NKY 2011-07-13 0.50% Not Available DXJ 2006-06-16 0.48% E*TRADE WisdomTree Japan Hedged Capital Goods ETF ( DXJC) 2014-04-08 0.48% Not Available WisdomTree Japan Hedged Financials ETF ( DXJF) 2014-04-08 0.48% E*TRADE WisdomTree Japan Hedged Health Care ETF ( DXJH) 2014-04-08 0.48% Not Available WisdomTree Japan Hedged Real Estate ETF (D XJR) 2014-04-08 0.48% E*TRADE WisdomTree Japan Hedged Tech, Media & Telecom ETF ( DXJT) 2014-04-08 0.48% Not Available EWJ 1996-03-12 0.48% 2 Platforms iShares Currency Hedged MSCI Japan ETF ( HEWJ) 2014-01-31 0.48% Not Available iShares MSCI Japan Small-Cap ETF ( SCJ) 2007-12-20 0.48% Not Available DBJP 2011-06-09 0.45% E*TRADE IQ 50 Percent Hedged FTSE Japan ETF ( HFXJ) 2015-07-22 0.45% Not Available WisdomTree Japan Dividend Growth Fund ( JDG) 2015-05-28 0.43% Not Available Deustche X-trackers Japan JPX-Nikkei 400 Equity ETF ( JPN) 2015-06-24 0.40% Not Available (Source etfdb.com) DXJ has an expense ratio of 0.48%, meaning that the fund will cost $4.8 in annual fees for every $1000 of investment, the average ETF however, carries an expense ratio of 0.44% (Morningstar Investment Research). DXJ costs more than the comparable Japanese ETF products and average ETFs. However, ETF implements strategy explained above is more efficient and cheaper than any other products. It is the perfect ETF for investors who are wary of currency changes but are bullish on Japanese stocks. Lastly, the Tokyo 2020 Olympic boost will definitely help Japan recover from the last two decades of economic torpor.

The WisdomTree Europe Dividend Growth ETF: Timing Is Everything

The fund is heavily weighted with best in class European companies. The fund is dividend weighted with a defensive bias. The poor performance seems to be a result of coming to market at the wrong time. Europe seems to have a split personality, at times somewhat fractious and recalcitrant and at other times cooperative and harmonious. The moribund Medieval Period was followed by a lively Renaissance. Centuries of religious wars were followed by an enlightened scientific revolution. In the 20th century, Europe engaged in decades of warfare not witnessed in all of human history. In the wake of that 20th century dark age, Europe determinedly embarked towards a second enlightenment. The basis for this hopeful new age is founded on equality, solidarity and prosperity, achieved through a unified economy. Europe has created an equitable, cooperative capitalism: carefully regulated and open. This new age has led to the creation of a sizable economy of well founded, well established global companies. An opportunity to participate in the potential growth of these companies may be had through the WisdomTree Europe Dividend Growth ETF (NYSEARCA: EUDG ). According to WisdomTree : … WisdomTree Europe Quality Dividend Growth Fund seeks to track the investment results of dividend-paying companies with growth characteristics in the European equity market … The tracking index is WisdomTree’s own proprietary index [DEFA]: … The Index is comprised of 300 companies from the eligible universe based on their combined ranking of growth and quality factors. The growth factor ranking is based on long-term earnings growth expectations, while the quality factor ranking is based on three year historical averages for return on equity and return on assets. Companies are weighted in the Index based on annual cash dividends paid. .. It seems that WisdomTree’s approach to dividend weighting results in a more conservative passive methodology than weighting by market price. An interesting description written by Mr. Jeremy D. Schwartz, titled “Dividends of a Dividend Approach ” , details the reasoning of the approach and the results. For example, it specifically takes into account, the importance of dividends in determining a stock’s price; the fact that dividends historically have provided the majority of the stock markets real return; dividends are an objective measure; dividends reflect management’s shareholder interest and lastly, the demand for income among baby boomers in retirement. The fund itself is a relative newcomer to the industry, incepted in May of 2014. If the fund is weighted by dividends and the quality of earnings, the top weightings should give a good indication of the risk to the investor. (click to enlarge) First it should be noted that the fund has about 200 holdings as of mid-October, however, just over 50% of the funds weighting is concentrated in its top holdings. There is something to point out in those top holdings. There seems to be a repetition of companies held. For example Roche Holdings ADRs on the OTC are assigned the symbol OTCQX:RHHBY . On the “Swiss-6” exchange, it’s ROG.VTX and on another Swiss exchange it’s Ro.SW. They all represent the same company and the same class of stock, hence Roche Holdings has a combined 8.31% weighting in the fund’s holdings. Similarly, Unilever is listed as UL on the NYSE, on the London exchange UNA, on the Amsterdam exchange as UNC as well as others. The point being that in the fund’s top holdings, Unilever holds a combined 3.98877% weighting and Roche 8.31% in the top fund’s holdings. By combining those ,means that the top 50% is really contained in the top 19 holdings, i.e., 9.5% of the fund. The top 50% of the fund is more heavily weighted in Consumer Staples, Health Care and Telecom Service than the entire fund. On the other hand, the top 50% is ‘lighter’ in Consumer Discretionary, Industrials, IT. Lastly the top half contains neither a Financial nor Material Sector allocation. It then appears that the more defensive sectors comprise the heaviest dividend weights. The more cyclical sectors are less weighted and more widely distributed among the fund’s 200 holdings. Below is a summary table of the top 50%, containing 19 companies with a relevant few metrics. Company Fund Weighting Yield Cash Flow Multiple Payout Ratio ROI/ROE Price/Earnings Price/Book Sector Roche [RHHBY] 8.31031% 3.06% 18.10 73.94% 20.07/48.00 23.37 10.96 Health Care British American Tobacco ( OTCPK:BTAFF ) 4.19366% 3.98% 14.71 46.50% 22.57/70.15 17.50 11.74 Consumer Non-Cyclical Anheuser-Busch (NYSE: BUD ) 4.02124% 3.11% 26.58 29.15% 10.25/19.29 19.38 3.77 Consumer Non-Cyclical Unilever [UL] 3.98877% 3.14% 17.37 41.40% 17.63/33.21 22.16 7.00 Consumer Non-Cyclical Novo Nordisk (NYSE: NVO ) 3.16913% 1.39% 21.09 41.30% 75.61/82.48 29.94 23.78 Health Care Bayer ( OTCPK:BAYRY ) 3.09927% 1.95% 14.14 53.35% 7.40/16.71 26.38 4.13 Health Care SAP (NYSE: SAP ) 2.35035% 1.79% 17.35 42.76% 11.82/16.66 23.46 3.47 IT Daimler ( OTCPK:DDAIF ) 2.32166% 3.41% 5.63 32.51% 6.82/17.81 9.62 1.98 Consumer Cyclical Diageo (NYSE: DEO ) 2.18663% 2.99% 15.88 59.43% 13.56/32.63 19.30 5.91 Consumer Non-Cyclical Telefonktiebolasget Ercsso [ERIC] 1.95709% 3.72% 13.59 109.29% 5.73/7.55 27.43 2.07 Telecom Service Inditex ( OTCPK:IDEXY ) 1.79386% 1.67% 26.14 29.56% 26.31/29.39 35.37 9.78 Consumer Cyclical Louis Vuitton ( OTCPK:LVMUY ) 1.73739% 1.92% 15.88 46.08% 9.29/12.71 24.76 3.02 Consumer Cyclical Hennes & Mauritz ( OTCPK:HNNMY ) 1.6948% 3.14% 16.43 *51.54% 41.57/44.71 23.82 9.98 Consumer Cyclical L’Oreal ( OTCPK:LRLCY ) 1.6825% 1.65% 23.28 *37.86% 11.80/12.90 31.27 3.99 Consumer Non-Cyclical Reckitt Benckiser ( OTCPK:RBGLY ) 1.66167% 2.14% 24.96 59.49% 16.66/24.90 28.23 6.90 Consumer Non-Cyclical ABB LTD (NYSE: ABB ) 1.62665% 3.12% 11.23 72.54% 9.54/15.73 16.94 2.90 Industrials Schneider Electric ( OTCPK:SBGSY ) 1.44748% 3.61% 11.19 *40.34% 6.20/9.03 17.64 1.50 Industrials Airbus Group ( OTCPK:EADSY ) 1.4196% 2.08% 9.04 *18.83% 5.61/32.83 16.54 7.94 Industrials Syngenta (NYSE: SYT ) 1.41046% 3.57% 14.77 *52.75% 10.39/15.68 20.92 3.42 Industrials Totals/Averages 50.07% 2.707368% 16.731 49.40% *estimated % of cash flow per share 17.30/28.55 22.84 22.84 The returns are anything but stellar, however, there’s an important reason for this. Returns 1 Month 3 Months 1 Year Since 5/7/2014 Inception WTEDG Index -2.87% -6.18% -6.28 -8.76 EUDG Fund -2.49% -6.56 -5.96 -9.21 The fund is not currency hedged. A comparison with the Euro vs the U.S. Dollar tells the story. (click to enlarge) The fund came to market precisely on the same day the Euro peaked in this time interval at $1.37 per Euro. From there it steadily trended lower to its current $1.12; just over an 18% decline. The fund closed its first day of trading at about $25.25. An 18.25% decline of the shares from that point works out to $20.64, just above its September 29 low of $20.05. Hence, when translated back to USD dollars, the value of the fund ‘shrank’ even though the top line companies continued to perform well. The currency translation is a very important point for the investor to keep in mind. When the European currencies weaken vs the U.S. Dollar, the NAV will decline, even if the companies in the fund are doing well . Hence, purchasing when the U.S. Dollar is strong is like purchasing the fund at a discount. Eventually, Europe will regain its economic footing and European currencies will appreciate against the U.S. Dollar, hence the potential for capital appreciation on a ‘dollar cost averaged’ investment. The same is true of European denominated dividends and distributions. The whole point of the matter is that for investors with risk capital, and the willingness to be patient while gradually accumulating a position knowing that the top 50% of the fund has an average yield of over 2.7% and the fund is defensively allocated, then it’s reasonable to assume that over a longer time horizon the future returns will outweigh current risk. The current poor returns are a matter of having a good idea, but extraordinarily bad timing.